Company intelligence / Profile preview
NBE-Therapeutics
Basel, Basel-Stadt, Switzerlandnbe-therapeutics.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
The company has developed a pipeline of ADC product candidates targeting solid tumors. Their next-generation ADC technology aims for long-lasting immune-oncology effects with the potential to reduce or eradicate tumors. Programs are at various stages of development up to clinical proof-of-concept[1][3].
No specific published clinical trial results were found in the provided sources.
Prior to acquisition, they had raised over $65 million in venture financing and $4 million from grants[2].
Now operates as a wholly owned subsidiary of Boehringer Ingelheim since December 2020[2].
Pipeline breadth and details on individual programs are not specified in public sources.
- Therapeutic areas
- Oncology
- Modalities
- Antibody-drug conjugates (ADCs)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Previously partnered with institutional investors including Boehringer Ingelheim Venture Fund, PPF Group, Novo Holdings; now part of Boehringer Ingelheim group[2]
Beyond the preview
Go deeper on NBE-Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NBE-Therapeutics.